Launch Of Palliatives For MSMEs: Job Creation By Professor Mojisola Christianah Adeyeye Director General NAFDAC, At NAFDAC Head Office Lagos
, Speech By Prof. Adeyeye C. M Director General NAFDAC Launch Of Palliatives For MSMEs: Job Creation At NAFDAC Head Office Lagos 15th May, 2020. Protocol His Excellency, Prof. Yemi Osinbajo, SAN, GCON, The Vice President, Federal Republic of Nigeria; The Hon. Minister of Health, Dr. Osagie Ehanire; The Managing Director, Bank of Industry; Mr […]
NAFDAC’s Position On Local Claims For Covid-19 Remedies
, The rush to mitigate the mortality and morbidly resulting from the COVID 19 pandemic has resulted in acceleration of product development, repurposing of formulations, off label use of therapeutics and the search for a vaccine to prevent COVID 19. Because no vaccine yet exists to prevent further spread of the virus, the huge burden […]
Disclaimer On The New Drug To Treatment Covid-19
, The attention of the Agency has been drawn to an advertorial from Pax Herbal Clinic and Research Laboratories titled “AN OFFICIAL STATEMENT BY PAXHERBALS ON THE TREATMENT OF COVID-19”. The advertorial claims that Paxherbal has developed a new drug called PAX CVD PLUS for the treatment of COVID-19 and is working with NAFDAC to […]
Semovita Does Not Contain Plastic Materials
, The attention of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to a social media video showing a woman washing Golden Penny Semovita in a sieve using cold water. The woman claimed that the residue she got after sieving was plastic. Upon receiving the alerts from various quarters […]
Covid-19 Personal Protection Equipment (PPEs) – Masks And Protective Clothing
, The National Agency for Food and Drug Administration and Control (NAFDAC) has the mandate to enlighten the public regarding the medical products needed for the nation’s response to the COVID-19 pandemic. As a result, the Agency has put in place an expedited registration pathway to allow the granting of Emergency Use Authorization (EUA) for […]
Public Alert No. 005/2020 – Alert on Falsified Chloroquine Products Circulating in WHO Region of Africa
, The National Agency for Food and Drugs Administration and Control (NAFDAC) has been informed by World Health Organization (WHO) that nine (9) confirmed falsified Chloroquine products are in circulation in the WHO region of Africa. Nine (9) reports of different confirmed falsified Chloroquine products from three African countries were received by WHO between 31st […]
NAFDAC Grants Conditional Emergency Use Approval of Medical Devices (COVID-19 Antibody and Antigen Test Kits, PPEs, etc.) Companies
, The National Agency for Food and Drug Administration and Control, pursuant to the powers conferred on it by section 5 of the NAFDAC Act, to regulate and control the manufacture, importation, exportation distribution sale, use and advertisement of Medical Devices, has taken some regulatory steps in the fight against COVID-19. The current COVID-19 pandemic has necessitated that NAFDAC put measures in place to ensure access to […]
Public Alert No. 004/2020 – Alert on Falsified Chloroquine Phosphate 250mg Tablets Circulating in Cameroon
, The National Agency for Food and Drugs Administration and Control (NAFDAC) has been notified by World Health Organization (WHO) on the circulation of falsified Chloroquine Phosphate 250mg tablets in Cameroon. The falsified Chloroquine Phosphate 250mg tablets are manufactured by Jiangsu Pharmaceutical Inc, Longchil Road, Ylxing, Jiangsu, China and Astral Pharmaceuticals, New Bhupalpura, Regd No: 0587612. The falsified […]
Public Alert No. 003/2020 – Alert on Illegal Distribution and Sale of Unregistered Hand Sanitizers.
, The National Agency for Food and Drug Administration and Control (NAFDAC) hereby alerts the public on illegal distribution and sale of unregistered Hand Sanitizers. The unregistered Hand Sanitizers are illegally distributed and sold under various names including: Mighti Shield Instant Hand Sanitizer. Assured Instant Hand Sanitizer. One Step Hand Sanitizer. Shield Germ Hand Sanitizer. […]
Director General Of NAFDAC Orders Manufacturing of Chloroquine for Emergency Stock for Possible Clinical Trial Treatment of Coronavirus (2019-nCoV)
, Chloroquine, an old antimalarial is being repurposed for the clinical trial treatment of Coronavirus 2019-nCoV. The drug was first tested in vitro (in the lab) using standard assays to measure the effects on the cytotoxicity, virus yield and infection rates of 2019-nCoV. The drug was reported to function as antiviral at both the entry […]
